TELISOTUZUMAB ADIZUTECAN
UNII CVX52RV2DC

Substance Identification & Data

This profile provides standardized clinical and technical data for Telisotuzumab Adizutecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CVX52RV2DC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2850366-99-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CVX52RV2DC
CAS Registry Number
2850366-99-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TELISOTUZUMAB ADIZUTECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13001
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Telisotuzumab Adizutecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TELISOTUZUMAB ADIZUTECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-700 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-700 .KAPPA.-CHAIN, DIMER, REDUCED, HEXAKIS(THIOETHER) WITH N-(2-MERCAPTOACETYL)-L-VALYL-N-(3-((7S)-7-ETHYL-7,8,11,13-TETRAHYDRO-7-HYDROXY-8,11-DIOXO-10H-1,3-DIOXOLO(4,5-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-14-YL)BICYCLO(1.1.1)PENT-1-YL)-L-ALANINAMIDE
TELISOTUZUMAB ADIZUTECAN [WHO-DD]